A trial drug for Polycystic Ovarian disease

Phase 2

Completed

• Conditions: Health Condition 1: null- Irregular Menstrual cycles

• Registration Number: CTRI/2014/06/004709
• Lead Sponsor: ational Institute of Siddha

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

•Irregular menstrual cycle: Eight or fewer menstrual cycles in the past year or intermenstrual periods of 45 days or longer.

•Patients having polycystic ovary on ultrasound should either have 12 or more follicles measuring 2-9 mm in diameter, or have an increased ovarian volume of 10 CC or greater

•Patient willing for Ultrasound abdomen and blood investigations.

•Patient willing to sign the informed consent

Exclusion Criteria

•Presence of any pelvic pathology such as chronic pelvic infection, Pelvic endometriosis, Adenomyosis, Uterine fibroid, Endometrial Polyp.

•Presence of secondary endocrine disorder such as hyperprolactinaemia, thyroid dysfunction.

•Patient using oral contraceptives or use of fertility drugs within 6 months

•Presence of any associated severe systemic illness.

Study & Design

• Study Type: Interventional
• Study Design: Not specified